Skip to main content
Premium Trial:

Request an Annual Quote

GeneFormatics Acquires License For Scripps Tech

Premium

LA JOLLA, Calif.--GeneForm-atics has acquired exclusive worldwide technology rights for a group of protein function identification algorithms invented at the Scripps Research Institute. These proprietary methods will be used to provide biologically relevant structure-based function predictions for genomic sequences for GeneFormatics' pharmaceutical and agricultural clients.

GeneFormatics descriptors of enzyme active sites, called Fuzzy Functional Forms (FFFs), will provide informatics techniques that are faster, simpler, more sensitive, and more accurate than current methods, GeneFormatics officials claimed.

"FFFs offer a significant advantage over current methods for sequence analysis and function prediction such as global sequence alignment and local sequence motif identification," said Jacquelyn Fetrow, coinventor of the technology, chief scientific officer of the company, and a former Scripps scientist. "Most of these methods are limited by the extent of the similarity between sequences of unknown and known function with the result that these methods increasingly fail as the sequence identity diverges into and beyond the twilight zone of sequence identity," Fetrow added.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.